A simple therapeutic nanoplatform in the second near-infrared window for synergistic phototherapy
Source abstract
Abstract
Abstract It is considerably meaningful to fabricate a second near-infrared spectral region (NIR-II, 1000–1700 nm) responsive theranostic nanoplatform simultaneously possessing good stability and biocompatibility for efficient and safe cancer treatment. In this work, as a flexible strategy, an intelligent nanoplatform was prepared by using water-soluble cyclic oligosaccharides α-cyclodextrin (α-CD) to load photosensitizer Chlorin e6 (Ce6) onto Fe3O4@Cu2−xS core−shell nanoparticles (NPs). The as-synthesized Fe3O4@Cu2−xS-Ce6/α-CD NPs are ultrasmall (≈5 nm) and aqueously dispersible, which offer both biocompatibility and renal clearance. Resultly, the obtained Fe3O4@Cu2−xS-Ce6/α-CD NPs feature remarkable absorption in the second near-infrared region (NIR-II), which can provide advantages of large penetration depth and high photothermal conversion efficiency (η = 67.88%). Additionally, the introduction of Ce6 can trigger the generation of 1O2 under visible light irradiation. Therefore, it provides the proof-of-concept application of functional materials in photodynamic and photothermal combination cancer therapy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Advanced Photocatalysis Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Cancer drug delivery in the nano era: an overview and perspectives (Review)10.3892/or.2017.5718 ↗
2. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
3. Bioactive MOFs based theranostic agent for highly effective combination of multimodal imaging and chemo-phototherapy10.1002/adhm.202000205 ↗
4. Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma10.1158/1078-0432.CCR-16-0870 ↗
5. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy10.1016/j.ejpb.2015.03.018 ↗
6. DNA repair dysregulation from cancer driver to therapeutic target10.1038/nrc3399 ↗
7. Manganese-doped layered double hydroxide: a biodegradable theranostic nanoplatform with tumor microenvironment response for magnetic resonance imaging-guided photothermal therapy10.1021/acsabm.0c00564 ↗
8. Doxorubicin-loaded Fe3O4@MoS2-PEG-2DG nanocubes as a theranostic platform for magnetic resonance imaging-guided chemo-photothermal therapy of breast cancer10.1007/s12274-017-1871-1 ↗
9. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer10.1038/s41467-018-03473-9 ↗
10. Nanocatalysts-augmented and photothermal-enhanced tumor-specific sequential nanocatalytic therapy in both NIR-I and NIR-II biowindows10.1002/adma.201805919 ↗
11. Rational design of conjugated small molecules for superior photothermal theranostics in the NIR-II biowindow
12. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
13. Oxygen-dependent regulation of excited-state deactivation process of rational photosensitizer for smart phototherapy10.1021/jacs.9b11800 ↗
14. Supramolecular photothermal effects: a promising mechanism for efficient thermal conversion10.1002/anie.201909825 ↗
15. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy10.1038/s41467-020-16513-0 ↗
16. “Hot” in plasmonics: temperature-related concepts and applications of metal nanostructures
17. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
18. Dual-targeted photothermal agents for enhanced cancer therapy10.1039/D0SC03173A ↗
19. Ultralow-intensity near infrared light synchronously activated collaborative chemo/photothermal/photodynamic therapy10.1039/C9BM01607D ↗
20. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms10.1039/C8NH00299A ↗
21. Compact plasmonic blackbody for cancer theranosis in the near-infrared II window10.1021/acsnano.7b08725 ↗
22. A full-spectrum-absorption from nickel sulphide nanoparticles for efficient NIR-II window photothermal therapy10.1039/C9NR04005F ↗
23. Multitriggered tumor-responsive drug delivery vehicles based on protein and polypeptide coassembly for enhanced photodynamic tumor ablation10.1002/smll.201602339 ↗
24. A novel theranostic nanoplatform based on Pd@Pt-PEG-Ce6 for enhanced photodynamic therapy by modulating tumor hypoxia microenvironment10.1002/adfm.201706310 ↗
25. Tumor microenvironment stimuli-responsive fluorescence imaging and synergistic cancer therapy by carbon-dot-Cu2+ nanoassemblies10.1002/anie.202007786 ↗
26. Sub-10 nm Fe3O4@Cu2-xS core shell nanoparticles for dual-modal imaging and photothermal therapy10.1021/ja4013497 ↗
27. Catalytically active, magnetically separable, and water-soluble FePt nanoparticles modified with cyclodextrin for aqueous hydrogenation reactions10.1039/b905331j ↗
28. Multifunctional theranostic nanoplatform based on Fe-mTa2O5@CuS-ZnPc/PCM for bimodal imaging and synergistically enhanced phototherapy10.1021/acs.inorgchem.7b02959 ↗
29. Luminescent gold nanoparticles with efficient renal clearance10.1002/anie.201007321 ↗
30. Renal clearance of quantum dots10.1038/nbt1340 ↗
31. Red-emitting upconverting nanoparticles for photodynamic therapy in cancer cells under near-infrared excitation10.1002/smll.201201437 ↗
32. Achieving high-performance photothermal and photodynamic effects upon combining D-A structure and nonplanar conformation
33. Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (or bleomycin) in mammalian cell inactivation10.1073/pnas.72.3.937 ↗